Sms Pharmaceuticals [SMSPHARMA] vs Sanofi India Limited [SANOFI] Detailed Stock Comparison

Sms Pharmaceuticals Ltd.

NSE
Loading...

Sanofi India Limited

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sms Pharmaceuticals Ltd. wins in 3 metrics, Sanofi India Limited wins in 17 metrics, with 0 ties. Sanofi India Limited appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sms Pharmaceuticals Ltd. Sanofi India Limited Better
P/E Ratio (TTM) 41.86 24.31 Sanofi India Limited
Price-to-Book Ratio 5.14 10.59 Sms Pharmaceuticals Ltd.
Debt-to-Equity Ratio 44.47 2.38 Sanofi India Limited
PEG Ratio 2.05 -0.97 Sms Pharmaceuticals Ltd.
EV/EBITDA 23.08 16.08 Sanofi India Limited
Profit Margin (TTM) 9.99% 17.78% Sanofi India Limited
Operating Margin (TTM) 15.98% 19.32% Sanofi India Limited
EBITDA Margin (TTM) 15.98% 19.32% Sanofi India Limited
Return on Equity 10.81% 40.59% Sanofi India Limited
Return on Assets (TTM) 6.00% 19.81% Sanofi India Limited
Free Cash Flow (TTM) $-416.71M $4.13B Sanofi India Limited
Dividend Yield 0.28% 4.60% Sanofi India Limited
1-Year Return 54.90% -49.23% Sms Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 4.39 4.32 Sanofi India Limited
Enterprise Value $39.23B $78.16B Sanofi India Limited
EV/Revenue Ratio 4.37 4.25 Sanofi India Limited
Gross Profit Margin (TTM) 35.59% 50.43% Sanofi India Limited
Revenue per Share (TTM) $96 $798 Sanofi India Limited
Earnings per Share (Diluted) $10.04 $141.75 Sanofi India Limited
Beta (Stock Volatility) 0.43 0.18 Sanofi India Limited

Sms Pharmaceuticals Ltd. vs Sanofi India Limited Stock Performance Analysis

Loading Price Chart...

SMSPHARMA
SANOFI

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sms Pharmaceuticals Ltd.-1.42%2.49%-5.59%3.24%16.68%20.59%
Sanofi India Limited3.84%2.46%0.71%-5.74%-22.80%-20.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sms Pharmaceuticals Ltd.54.90%314.99%124.70%340.29%1,909.70%1,070.48%
Sanofi India Limited-49.23%-54.97%-58.99%-25.65%55.45%103.00%

Performance & Financial Health Analysis: Sms Pharmaceuticals Ltd. vs Sanofi India Limited

MetricSMSPHARMASANOFI
Market Information
Market Cap i₹37.15B₹79.35B
Market Cap CategorySmall capMid cap
10 Day Avg. Volume i317,78246,430
90 Day Avg. Volume i392,41536,764
Last Close₹378.00₹3,240.70
52 Week Range₹207.70 - ₹447.80₹3,054.00 - ₹6,410.00
% from 52W High-15.59%-49.44%
All-Time High₹447.80 (Apr 15, 2026)₹10,524.95 (Jun 10, 2024)
% from All-Time High-15.59%-69.21%
Growth Metrics
Quarterly Revenue Growth0.21%-0.19%
Quarterly Earnings Growth0.29%-0.33%
Financial Health
Profit Margin (TTM) i0.10%0.18%
Operating Margin (TTM) i0.16%0.19%
Return on Equity (TTM) i0.11%0.41%
Debt to Equity (MRQ) i44.472.38
Cash & Liquidity
Book Value per Share (MRQ)₹81.83₹325.31
Cash per Share (MRQ)₹11.00₹114.15
Operating Cash Flow (TTM) i₹1.03B₹4.38B
Levered Free Cash Flow (TTM) i₹691.36M₹3.58B
Dividends
Last 12-Month Dividend Yield i0.28%4.60%
Last 12-Month Dividend i₹0.80₹192.00

Valuation & Enterprise Metrics Analysis: Sms Pharmaceuticals Ltd. vs Sanofi India Limited

MetricSMSPHARMA (Apr 24, 2026)SANOFI (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i41.8624.31
Forward P/E iN/A19.43
PEG Ratio i2.05-0.97
Price to Sales (TTM) i4.394.32
Price to Book (MRQ) i5.1410.59
Market Capitalization
Market Capitalization i₹37.15B₹79.35B
Enterprise Value i₹39.23B₹78.16B
Enterprise Value Metrics
Enterprise to Revenue i4.374.25
Enterprise to EBITDA i23.0816.08
Risk & Other Metrics
Beta i0.430.18
Book Value per Share (MRQ) i₹81.83₹325.31

Financial Statements Comparison: Sms Pharmaceuticals Ltd. vs Sanofi India Limited

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSMSPHARMA (2025)SANOFI (2025)
Revenue/Sales i7.79B18.23B
Cost of Goods Sold i5.23B9.06B
COGS % of Revenue i67.2%49.7%
Gross Profit i2.56B9.18B
Gross Margin i32.8%50.3%
Research & Development i128.31MN/A
Operating Income (EBIT) i1.05B4.54B
Operating Margin i13.4%24.9%
EBITDA i1.44B5.10B
EBITDA Margin i18.5%28.0%
Pre-Tax Income i923.38M4.45B
Pre-Tax Income % of Revenue i11.8%24.4%
Income Tax i249.39M1.18B
Income Tax % of Revenue i3.2%6.5%
Net Income (Profit) i691.35M3.27B
Profit Margin i8.9%17.9%

Balance Sheet & Liquidity Metrics

MetricSMSPHARMA (2025)SANOFI (2025)
Cash & Equivalents i413.99M2.63B
Total Current Assets i5.54B8.01B
Total Current Assets % of Revenue i71.2%43.9%
Total Current Liabilities i3.24B4.91B
Total Current Liabilities % of Revenue i41.6%26.9%
Long-Term Debt i1.39B137.00M
Long-Term Debt % of Revenue i17.9%0.8%
Total Shareholders Equity i6.40B7.49B
Retained Earnings i3.80B3.32B
Retained Earnings % of Revenue i48.8%18.2%
Property, Plant & Equipment i298.39M3.03B

Cash Flow Statement Comparison

MetricSMSPHARMA (2025)SANOFI (2025)
Operating Cash Flow i1.03B7.22B
Operating Cash Flow % of Revenue i13.2%39.6%
Capital Expenditures i-1.23B-253.00M
Free Cash Flow i-416.71M4.13B
FCF Margin i-5.3%22.6%
Debt Repayment i-440.97MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSMSPHARMASANOFI
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i93.65M23.03M
Float Shares i22.56M9.07M
% Held by Insiders i75.05%60.61%
% Held by Institutions i3.21%24.40%
% Held by Public i21.74%14.99%

Dividend Analysis & Yield Comparison: Sms Pharmaceuticals Ltd. vs Sanofi India Limited

MetricSMSPHARMASANOFI
Last 12-Month Dividend i₹0.80₹192.00
Last 12-Month Dividend Yield i0.28%4.60%
3-Year Avg Annual Dividend i₹0.37₹245.33
3-Year Avg Dividend Yield i0.16%2.49%
3-Year Total Dividends i₹1.10₹736.00
Ex-Dividend DateSep 22, 2025Nov 07, 2025